PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
June 08, 2023 09:00 ET
|
ResMed Inc.
The studies also showed 18-40% lower costs incurred from ER visits and hospitalizations after 1 year for PAP-adherent OSA patients with diastolic and systolic heart failure, respectivelyA third study...
ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference
June 05, 2023 16:05 ET
|
ResMed Inc.
SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the Goldman Sachs...
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023
May 25, 2023 09:00 ET
|
ResMed Inc.
France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with OSAGermany’s Michael Arzt presented...
ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer
May 02, 2023 16:05 ET
|
ResMed Inc.
Rider and Haake, both internal promotions, joined ResMed’s executive team on May 1Rider, currently Senior Vice President, Deputy Global General Counsel will succeed retiring Chief Administrative...
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023
April 27, 2023 16:05 ET
|
ResMed Inc.
Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD)...
ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023
April 06, 2023 16:05 ET
|
ResMed Inc.
SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2023 on...
ResMed Chief Administrative Officer and Global General Counsel to Retire
March 30, 2023 16:05 ET
|
ResMed Inc.
ResMed to conduct an internal search for a successor general counselAmy Wakeham appointed Chief Communications and Investor Relations Officer, will join ResMed’s executive leadership team SAN DIEGO,...
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
March 15, 2023 16:19 ET
|
ResMed Inc.
SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life...
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
March 13, 2023 07:00 ET
|
ResMed Inc.
81% of respondents experience one or more symptoms indicating poor sleep quality, despite 64% saying they’re satisfied with the quantity of their sleepWomen and older generations are less satisfied...
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023 09:00 ET
|
ResMed Inc.
SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 33rd Annual Healthcare...